NAVA — Navamedic ASA Income Statement
0.000.00%
Last trade - 00:00- NOK471.23m
- NOK596.00m
- NOK565.36m
Annual income statement for Navamedic ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 278 | 382 | 512 | 531 | 565 |
| Cost of Revenue | |||||
| Gross Profit | 112 | 164 | 199 | 209 | 220 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 267 | 328 | 506 | 511 | 553 |
| Operating Profit | 11.5 | 54 | 6.18 | 19.9 | 12.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 2.36 | 42.5 | -6.16 | -1.62 | -15.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.618 | 29.4 | -13.7 | -5.49 | -23.5 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.618 | 29.4 | -13.7 | -5.49 | -23.5 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.618 | 29.4 | -13.7 | -5.49 | -23.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.037 | 1.3 | 0.459 | 0.125 | -0.982 |
| Dividends per Share |